Article Information
vol. 10 no. 422
- Received for publication January 17, 2017
- Resubmitted September 8, 2017
- Accepted for publication November 27, 2017
- .
Author Information
- Adel Samson1,*,
- Karen J. Scott1,†,
- David Taggart1,†,
- Emma J. West1,
- Erica Wilson1,
- Gerard J. Nuovo2,
- Simon Thomson3,
- Robert Corns3,
- Ryan K. Mathew1,
- Martin J. Fuller1,
- Timothy J. Kottke4,
- Jill M. Thompson4,
- Elizabeth J. Ilett1,
- Julia V. Cockle1,
- Philip van Hille3,
- Gnanamurthy Sivakumar3,
- Euan S. Polson1,
- Samantha J. Turnbull1,
- Elizabeth S. Appleton1,
- Gemma Migneco1,
- Ailsa S. Rose1,
- Matthew C. Coffey5,
- Deborah A. Beirne3,
- Fiona J. Collinson6,
- Christy Ralph1,
- D. Alan Anthoney1,
- Christopher J. Twelves1,
- Andrew J. Furness7,
- Sergio A. Quezada7,
- Heiko Wurdak1,
- Fiona Errington-Mais1,
- Hardev Pandha8,
- Kevin J. Harrington9,
- Peter J. Selby1,
- Richard G. Vile4,
- Stephen D. Griffin1,
- Lucy F. Stead1,
- Susan C. Short1,*,‡ and
- Alan A. Melcher9,*,‡
- 1Leeds Institute of Cancer and Pathology, Faculty of Medicine and Health, University of Leeds, St James’s University Hospital, Beckett Street, Leeds, West Yorkshire LS9 7TF, UK.
- 2Ohio State University, Comprehensive Cancer Centre, Columbus, OH 43210, USA.
- 3Leeds Teaching Hospitals National Health Service Trust, St James’s University Hospital, Beckett Street, Leeds, West Yorkshire LS9 7TF, UK.
- 4Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
- 5Oncolytics Biotech, Calgary, Alberta T2N 1X7, Canada.
- 6Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK.
- 7University College London, London WC1 6BT, UK.
- 8University of Surrey, Guildford GU2 7XH, UK.
- 9Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK.
- ↵*Corresponding author. Email: a.samson{at}leeds.ac.uk (A.S.); alan.melcher{at}icr.ac.uk (A.A.M.); s.c.short{at}leeds.ac.uk (S.C.S.)